These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

856 related items for PubMed ID: 19709503

  • 1. Baseline characteristics and outcomes in patients with first episode or multiple episodes of acute mania.
    Tohen M, Vieta E, Gonzalez-Pinto A, Reed C, Lin D, European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM) Advisory Board.
    J Clin Psychiatry; 2010 Mar; 71(3):255-61. PubMed ID: 19709503
    [Abstract] [Full Text] [Related]

  • 2. Predictors of switching from mania to depression in a large observational study across Europe (EMBLEM).
    Vieta E, Angst J, Reed C, Bertsch J, Haro JM, EMBLEM advisory board.
    J Affect Disord; 2009 Nov; 118(1-3):118-23. PubMed ID: 19269690
    [Abstract] [Full Text] [Related]

  • 3. Why do clinicians maintain antidepressants in some patients with acute mania? Hints from the European Mania in Bipolar Longitudinal Evaluation of Medication (EMBLEM), a large naturalistic study.
    Rosa AR, Cruz N, Franco C, Haro JM, Bertsch J, Reed C, Aarre TF, Sanchez-Moreno J, Vieta E.
    J Clin Psychiatry; 2010 Aug; 71(8):1000-6. PubMed ID: 20361912
    [Abstract] [Full Text] [Related]

  • 4. [Clinical particularism of bipolar disorder: unipolar mania. About a patient's study in Tunesia].
    Dakhlaoui O, Essafi I, Haffani F.
    Encephale; 2008 Sep; 34(4):337-42. PubMed ID: 18922234
    [Abstract] [Full Text] [Related]

  • 5. Mania in the Nordic countries: patients and treatment in the acute phase of the EMBLEM study.
    Larsen JK, Porsdal V, Aarre TF, Koponen HJ, Aarnio J, Kleivenes OK, Emblem Advisory Board.
    Nord J Psychiatry; 2009 Sep; 63(4):285-91. PubMed ID: 19140076
    [Abstract] [Full Text] [Related]

  • 6. Chronic mania revisited: factors associated with treatment non-response during prospective follow-up of a large European cohort (EMBLEM).
    Van Riel WG, Vieta E, Martinez-Aran A, Haro JM, Bertsch J, Reed C, Van Os J.
    World J Biol Psychiatry; 2008 Sep; 9(4):313-20. PubMed ID: 18949649
    [Abstract] [Full Text] [Related]

  • 7. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state.
    Medda P, Perugi G, Zanello S, Ciuffa M, Rizzato S, Cassano GB.
    J ECT; 2010 Jun; 26(2):82-6. PubMed ID: 19710623
    [Abstract] [Full Text] [Related]

  • 8. Clinical features, response to treatment and functional outcome of bipolar disorder patients with and without co-occurring substance use disorder: 1-year follow-up.
    Mazza M, Mandelli L, Di Nicola M, Harnic D, Catalano V, Tedeschi D, Martinotti G, Colombo R, Bria P, Serretti A, Janiri L.
    J Affect Disord; 2009 May; 115(1-2):27-35. PubMed ID: 18845344
    [Abstract] [Full Text] [Related]

  • 9. Functional impairment in patients with mania: baseline results of the EMBLEM study.
    Goetz I, Tohen M, Reed C, Lorenzo M, Vieta E, EMBLEM Advisory Board.
    Bipolar Disord; 2007 May; 9(1-2):45-52. PubMed ID: 17391349
    [Abstract] [Full Text] [Related]

  • 10. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH, Dunner DL.
    Depress Anxiety; 2008 May; 25(2):91-7. PubMed ID: 17311265
    [Abstract] [Full Text] [Related]

  • 11. Suicidal attempts in bipolar disorder: results from an observational study (EMBLEM).
    Bellivier F, Yon L, Luquiens A, Azorin JM, Bertsch J, Gerard S, Reed C, Lukasiewicz M.
    Bipolar Disord; 2011 Jun; 13(4):377-86. PubMed ID: 21843277
    [Abstract] [Full Text] [Related]

  • 12. Rapid-cycling bipolar I disorder: course and treatment outcome of a large sample across Europe.
    Cruz N, Vieta E, Comes M, Haro JM, Reed C, Bertsch J, EMBLEM Advisory Board.
    J Psychiatr Res; 2008 Oct; 42(13):1068-75. PubMed ID: 18262204
    [Abstract] [Full Text] [Related]

  • 13. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS, Konarski JZ, Jones M, Paulsson B.
    J Affect Disord; 2007 Oct; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [Abstract] [Full Text] [Related]

  • 14. A double-blind, placebo-controlled pilot study of quetiapine for depressed adolescents with bipolar disorder.
    DelBello MP, Chang K, Welge JA, Adler CM, Rana M, Howe M, Bryan H, Vogel D, Sampang S, Delgado SV, Sorter M, Strakowski SM.
    Bipolar Disord; 2009 Aug; 11(5):483-93. PubMed ID: 19624387
    [Abstract] [Full Text] [Related]

  • 15. Risperidone safety and efficacy in the treatment of bipolar and schizoaffective disorders: results from a 6-month, multicenter, open study.
    Vieta E, Goikolea JM, Corbella B, Benabarre A, Reinares M, Martínez G, Fernández A, Colom F, Martínez-Arán A, Torrent C, Group for the Study of Risperidone in Affective Disorders (GSRAD).
    J Clin Psychiatry; 2001 Oct; 62(10):818-25. PubMed ID: 11816872
    [Abstract] [Full Text] [Related]

  • 16. The management of bipolar mania: a national survey of baseline data from the EMBLEM study in Italy.
    Bellantuono C, Barraco A, Rossi A, Goetz I.
    BMC Psychiatry; 2007 Jul 19; 7():33. PubMed ID: 17640381
    [Abstract] [Full Text] [Related]

  • 17. Observational study designs for bipolar disorder - what can they tell us about treatment in acute mania?
    Reed C, Novick D, Gonzalez-Pinto A, Bertsch J, Haro JM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun 15; 33(4):715-21. PubMed ID: 19345251
    [Abstract] [Full Text] [Related]

  • 18. [Management of patients with acute manic or mixed episodes and outcome at three months].
    Azorin JM, Luquiens A, Aubrun E, Reed C, Gasquet I, Lukasiewicz M.
    Encephale; 2010 Jun 15; 36(3):226-35. PubMed ID: 20620265
    [Abstract] [Full Text] [Related]

  • 19. 2-Year course of bipolar disorder type I patients in outpatient care: factors associated with remission and functional recovery.
    Haro JM, Reed C, Gonzalez-Pinto A, Novick D, Bertsch J, Vieta E, EMBLEM Advisory Board.
    Eur Neuropsychopharmacol; 2011 Apr 15; 21(4):287-93. PubMed ID: 20956071
    [Abstract] [Full Text] [Related]

  • 20. Validation of a severity threshold for the Mania Rating Scale: a receiver-operating characteristic analysis.
    Azorin JM, Kaladjian A, Akiskal HS, Hantouche EG, Duchêne LC, Gury C, Lancrenon S.
    Psychopathology; 2007 Apr 15; 40(6):453-60. PubMed ID: 17709976
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.